U.S. flag

An official website of the United States government

NM_006494.4(ERF):c.266A>G (p.Tyr89Cys) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 17, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002518789.2

Allele description [Variation Report for NM_006494.4(ERF):c.266A>G (p.Tyr89Cys)]

NM_006494.4(ERF):c.266A>G (p.Tyr89Cys)

Gene:
ERF:ETS2 repressor factor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_006494.4(ERF):c.266A>G (p.Tyr89Cys)
HGVS:
  • NC_000019.10:g.42249934T>C
  • NG_042802.1:g.10231A>G
  • NM_001301035.2:c.41A>G
  • NM_001308402.2:c.41A>G
  • NM_001312656.2:c.41A>G
  • NM_006494.4:c.266A>GMANE SELECT
  • NP_001287964.1:p.Tyr14Cys
  • NP_001295331.1:p.Tyr14Cys
  • NP_001299585.1:p.Tyr14Cys
  • NP_006485.2:p.Tyr89Cys
  • NC_000019.9:g.42754086T>C
  • NM_006494.2:c.266A>G
Protein change:
Y14C; TYR89CYS
Links:
OMIM: 611888.0008; dbSNP: rs886041001
NCBI 1000 Genomes Browser:
rs886041001
Molecular consequence:
  • NM_001301035.2:c.41A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001308402.2:c.41A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001312656.2:c.41A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006494.4:c.266A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003564122Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Dec 17, 2021)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the ERF gene.

Balasubramanian M, Lord H, Levesque S, Guturu H, Thuriot F, Sillon G, Wenger AM, Sureka DL, Lester T, Johnson DS, Bowen J, Calhoun AR, Viskochil DH; DDD Study., Bejerano G, Bernstein JA, Chitayat D.

J Med Genet. 2017 Mar;54(3):157-165. doi: 10.1136/jmedgenet-2016-104143. Epub 2016 Oct 13.

PubMed [citation]
PMID:
27738187

Molecular analysis provides further evidence that Chitayat syndrome is caused by the recurrent p.(Tyr89Cys) pathogenic variant in the ERF gene.

Caro-Contreras A, Alcántara-Ortigoza MA, Ahumada-Pérez JF, González-Del Angel A.

Am J Med Genet A. 2019 Jan;179(1):118-122. doi: 10.1002/ajmg.a.60676. Epub 2018 Dec 20.

PubMed [citation]
PMID:
30569521
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV003564122.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The c.266A>G (p.Y89C) alteration is located in exon 3 (coding exon 3) of the ERF gene. This alteration results from a A to G substitution at nucleotide position 266, causing the tyrosine (Y) at amino acid position 89 to be replaced by a cysteine (C). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration is a recurrent alteration reported in multiple unrelated individuals with Chitayat syndrome. This alteration occurred de novo in at least three separate patients and was inherited from an affected parent in two families (Balasubramanian, 2016; Caro-Contreras, 2019; Shin, 2019; Suter, 2020; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024